Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc. | EVP & General Counsel | Common Stock | 113K | $289K | $2.56 | Mar 10, 2025 | Direct |
Sana Biotechnology, Inc. | EVP & General Counsel | Restricted Stock Units | 33.1K | $84.8K | $2.56 | Mar 7, 2025 | Direct |
Sana Biotechnology, Inc. | EVP & General Counsel | Stock Option (Right to Buy) | 240K | Mar 6, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SANA | Sana Biotechnology, Inc. | Mar 6, 2025 | 5 | -$7.25K | 4 | Mar 10, 2025 | EVP & General Counsel |
SANA | Sana Biotechnology, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 8, 2024 | EVP & General Counsel |
SANA | Sana Biotechnology, Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 3, 2023 | EVP & General Counsel |
SANA | Sana Biotechnology, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 16, 2022 | EVP & General Counsel |
SANA | Sana Biotechnology, Inc. | Sep 12, 2022 | 0 | $0 | 3/A | Sep 20, 2022 | EVP & General Counsel |